共 119 条
- [1] Siegel R(2012)Cancer treatment and survivorship statistics, 2012 CA Cancer J Clin. 62 220-241
- [2] DeSantis C(2000)Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma: an outcomes trial Cancer. 89 314-327
- [3] Virgo K(2011)Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer Ann Surg Oncol. 18 619-627
- [4] Snady H(2012)Pancreatic adenocarcinoma: outstanding problems World J Gastrointest Surg. 4 104-113
- [5] Bruckner H(2009)Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement Ann Surg Oncol. 16 1736-1744
- [6] Cooperman A(1979)Carcinoma of the pancreas and periampullary region Ann Surg. 189 129-138
- [7] Paradiso J(2001)Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial Ann Surg. 234 758-768
- [8] Kiefer L(2000)Resected adenocarcinoma of the pancreas—616 patients: results, outcomes, and prognostic indicators J Gastrointest Surg. 4 567-579
- [9] Stokes JB(2009)William Traverso L, Linehan DC. Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement Ann Surg Oncol. 16 1727-1733
- [10] Nolan NJ(2006)Borderline resectable pancreatic cancer: a new classification for an old challenge Ann Surg Oncol. 13 1019-1020